Lisa R. Tannock, M.D.

Bio / Education: 

University of Toronto, Toronto, Canada




University of Toronto, Toronto, Canada



Internal Medicine

University of Washington, Seattle, WA




Selected Publications: 

1. Tannock LR, Little PJ, Wight TN, Chait A: Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced LDL binding. J Lipid Res 43:149-157, 2002. PMID:11792734.
2. Tannock LR, Little PJ, Tsoi C, Barrett PHR, Wight TN, Chait A: Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans. Diabetologia. 47:837-843, 2004. PMID:15071727.
3. Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest. 114:659-668, 2004. PMID:15343384 :PMC514580
4. Tannock LR, O’Brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, Kahn SE, Chait A: Cholesterol feeding increases CRP and SAA levels in lean, insulin sensitive subjects. Circulation 111:3058-3062, 2005. PMID:15939816.
5. Tannock LR, Kirk EA, King VL, LeBoeuf R, Wight TN, Chait A: Glucosamine Supplementation Accelerates Early but not Late Atherosclerosis in LDL Receptor Deficient Mice. J Nutr 136:2856-2861, 2006. PMID:17056813.

PubMed Publications: 

  • Grandoch, M.;Kohlmorgen, C.;Melchior-Becker, A.;Feldmann, K.;Homann, S.;Müller, J.;Kiene, L.S.;Zeng-Brouwers, J.;Schmitz, F.;Nagy, N.;Polzin, A.;Gowert, N.S.;Elvers, M.;Skroblin, P.;Yin, X.;Mayr, M.;Schaefer, L.;Tannock, L.R.;Fischer, J.W. "Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis." Arteriosclerosis, thrombosis, and vascular biology 36, 5 (2016): e41-50. [PubMed Link] | [ Full text ]
  • Hager, M.R.;Narla, A.D.;Tannock, L.R. "Dyslipidemia in patients with chronic kidney disease." Reviews in endocrine & metabolic disorders (2016): [PubMed Link] | [ Full text ]